Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05571397 · ClinicalTrials.gov registry record · Phase 1

Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes

A Phase 1 study of Hyperglycemia, sponsored by Ohio State University.

Completed
Registry status
Phase 1
Development phase
201
Enrollment target
1
Study location

NCT05571397 is a Phase 1 study of Hyperglycemia that has completed, run by Ohio State University. The registered enrollment target is 201 participants, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05571397, a Phase 1 study of Hyperglycemia, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
Phase 1
Development phase
201 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this implementation study is to assess the feasibility of real time continuous glucose monitoring (CGM) implementation using a CGM plus (+) point-of-care (POC) protocol among patients on IV insulin or those with hyperglycemia (\>250mg/dl) in the critical care hospital environments.

Conditions Studied

Interventions

  • DEVICE Dexcom G6

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2023-11-01
Est. Completion 2024-09-19
Phase Phase 1

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT05571397

The ClinicalTrials.gov registry entry for NCT05571397 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 1 intervention - of which Dexcom G6 is the first listed.

NCT05571397 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05571397 about?

NCT05571397 is a clinical study titled "Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes". The primary objective of this implementation study is to assess the feasibility of real time continuous glucose monitoring (CGM) implementation using a CGM plus (+) point-of-care (POC) protocol among patients on IV insulin or those with hyperglycemia (\>250mg/dl) in the critical care hospital enviro...

What is the current status of trial NCT05571397?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 201 participants. The study started on 2023-11-01. Estimated completion is 2024-09-19.

What conditions does trial NCT05571397 study?

This clinical trial studies the following conditions: Hyperglycemia.

What interventions are being tested in trial NCT05571397?

The interventions under investigation include: Dexcom G6 (DEVICE).

Who is sponsoring clinical trial NCT05571397?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05571397 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hyperglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.